ConductScience.org, home

Gene · 4921

Papers2,653

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1,561 to 1,580 of 2,653

Download this page as JSON
TitleJournalYearPMIDFound bySource
Discovery and optimization of a series of 3-substituted indazole derivatives as multi-target kinase inhibitors for the treatment of lung squamous cell carcinoma.Eur J Med Chem201930572178PubTator, text miningPubMed
Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain.Med Res Rev201930565725PubTator, text miningPubMed
Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients.Transl Oncol201930562681PubTator, text miningPubMed
Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.Head Neck201930548484PubTator, text miningPubMed
Orange is the new black: Kinases are the new master regulators of tumor suppression.IUBMB Life201930548122PubTator, text miningPubMed
MEK inhibitor enhanced the antitumor effect of oxaliplatin and 5‑fluorouracil in MEK1 Q56P‑mutant colorectal cancer cells.Mol Med Rep201930535504PubTator, text miningPubMed
Novel NTRK3 Fusions in Fibrosarcomas of Adults.Am J Surg Pathol201930520818PubTator, text miningPubMed
Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies.Mod Pathol201930459450PubTator, text miningPubMed
Clustering, Spatial Distribution, and Phosphorylation of Discoidin Domain Receptors 1 and 2 in Response to Soluble Collagen I.J Mol Biol201930458172PubTator, text miningPubMed
DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome.ACS Chem Biol201930452219PubTator, text miningPubMed
Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity.Aging Cell201930450724PubTator, text miningPubMed
A Pilot Prospective Study of Refractory Solid Tumor Patients for NGS-Based Targeted Anticancer Therapy.Transl Oncol201930448735PubTator, text miningPubMed
Models of osteoarthritis: the good, the bad and the promising.Osteoarthritis Cartilage201930391394PubTator, text miningPubMed
Diverse assays from a single skin punch biopsy to assess topical drug intervention.Br J Dermatol201930367471PubTator, text miningPubMed
Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate Cancer.Clin Cancer Res201930327304PubTator, text miningPubMed
Genomic Characterization of TP53-Wild-Type Esophageal Carcinoma.Transl Oncol201930317074PubTator, text miningPubMed
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application.J Med Chem201930188734PubTator, text miningPubMed
Molecular characterization of cancers with NTRK gene fusions.Mod Pathol201930171197PubTator, text miningPubMed
Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family.Hum Pathol201930130630PubTator, text miningPubMed
Biomarkers for the identification of cardiac fibroblast and myofibroblast cells.Heart Fail Rev201929987445PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4921/papers?page=79